INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Indaptus Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.73+0.10 (+3.80%)

Close on Oct 19, 2026

Market cap: $317.04M
P/E (TTM): –
Dividend yield: –

Indaptus Therapeutics, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31
Cash & Equivalents	7.55	1.50	8.51	5.83	6.16	3.89	5.79	7.38	7.30	9.74	13	16	13	6.81	9.63	6.72	14	33	39	42	17	–	1.64	–	14	–	–
Short-Term Investments	4.00	–	–	–	–	–	–	–	–	–	–	–	6.99	15	17	22	19	2.96	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	12	1.50	8.51	5.83	6.16	3.89	5.79	7.38	7.30	9.74	13	16	20	22	26	28	33	36	39	42	17	–	1.64	–	14	–	–
Prepaid Expenses & Other	0.43	0.68	0.80	0.61	0.26	1.07	0.83	0.25	0.19	0.55	0.63	0.88	0.18	0.47	0.81	1.13	0.26	0.74	1.11	1.40	0.80	–	0.09	–	–	–	–
Other Current Assets	0.03	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Assets	–	2.18	9.31	6.44	6.41	4.96	6.62	7.63	7.49	10	14	17	20	22	27	30	33	37	40	44	19	–	1.73	–	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–	–	0.00	–	–	–	–
Operating Lease Right-of-Use Assets	–	–	–	0.01	0.03	0.06	0.08	0.11	0.13	0.15	0.17	0.19	0.22	0.24	0.08	0.10	0.12	0.15	0.17	–	–	–	0.82	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.20	–	–	–	–	–	–
Other Long-Term Assets	–	–	–	0.39	0.39	0.39	0.64	0.50	0.50	0.50	0.75	0.75	0.75	0.75	0.74	0.75	0.66	0.02	0.02	–	1.30	–	0.04	–	–	–	–
Total Assets	12	–	9.31	6.84	6.84	5.41	7.34	8.24	8.12	11	15	18	21	23	28	30	34	37	41	44	20	–	1.78	–	–	–	–
Accounts Payable	0.51	0.56	0.54	0.71	0.62	1.31	0.87	0.56	0.42	0.41	0.81	0.62	0.75	0.38	1.38	1.25	2.43	2.83	2.54	3.34	5.04	–	0.16	–	–	–	–
Accrued Expenses	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.07	–	2.86	–	–	–	–
Current Portion of Leases	–	–	–	0.01	0.03	0.06	0.08	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.08	0.10	0.10	0.10	0.10	–	0.63	–	0.60	–	–	–	–
Current Income Taxes Payable	–	0.00	0.08	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	–	0.93	6.16	2.23	8.51	2.61	3.39	2.23	1.93	1.54	2.77	2.37	2.10	1.82	3.43	2.88	3.62	3.68	4.60	5.78	5.44	–	2.02	–	–	–	–
Long-Term Leases	–	–	–	–	–	–	–	0.00	0.03	0.05	0.07	0.10	0.12	0.14	–	0.00	0.03	0.05	0.07	–	–	–	0.34	–	–	–	–
Operating Lease Liabilities	–	–	–	0.01	0.03	0.06	0.08	0.11	0.13	0.15	0.18	0.20	0.22	0.24	0.08	0.10	0.13	0.15	0.17	–	0.63	–	0.93	–	–	–	–
Other Long-Term Liabilities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.72	–	0.69	–	–	–	–
Total Liabilities	0.62	0.93	6.16	2.23	8.51	2.61	3.39	2.24	1.96	1.59	2.85	2.46	2.22	1.96	3.43	2.89	3.65	3.73	4.68	5.78	6.16	–	2.02	–	–	–	–
Preferred Stock	–	–	0.01	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.01	–	–	–	–
Common Stock	1.33	1.13	0.02	0.02	0.01	0.16	0.00	0.10	0.09	0.09	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.73	–	0.02	–	–	–	–
Additional Paid-In Capital	96	84	84	78	69	68	64	62	59	58	57	57	56	55	54	54	53	52	51	50	228	–	7.69	–	–	–	–
Retained Earnings	-86	-84	-81	-73	-70	-65	-60	-56	-53	-49	-45	-41	-37	-34	-30	-26	-23	-19	-16	-12	-215	–	-7.96	–	–	–	–
Comprehensive Income & Other	–	–	–	–	–	–	–	–	–	–	–	–	0.13	0.18	0.10	0.02	-0.03	-0.01	–	–	–	–	–	–	–	–	–
Shareholders' Equity	11	1.25	3.15	4.61	-1.67	2.80	3.94	6.00	6.17	9.36	12	15	19	21	25	28	30	33	36	38	-1.32	-0.83	-0.24	0.00	2.02	2.69	3.21
Total Equity	11	1.25	3.15	4.61	-1.67	2.80	3.94	6.00	6.17	9.36	12	15	19	21	25	28	30	33	36	38	-1.32	-0.83	-0.24	0.00	2.02	2.69	3.21
Total Liabilities & Equity	12	2.18	9.31	6.84	6.84	5.41	7.34	8.24	8.12	11	15	18	21	23	28	30	34	37	41	44	20	–	1.78	–	–	–	–
Shares Outstanding(shares)	133	113	2.17	1.64	17	0.56	0.43	0.36	0.30	0.30	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.07	–	0.07	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -587.6%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: 27.88
Dividend yield: –